Characteristics | Value (%) |
---|---|
Total patients 43 | |
Age (years), median (range) | 57, 15–81 |
Gender | |
Male | 32 (74%) |
Female | 11 (26%) |
Primary site | |
Oropharynx | 19 (44.2%) |
Nasopharynx | 9 (21%) |
Larynx | 8 (18.6%) |
Salivary glands | 4 (9.3%) |
Occult | 2 (4.6%) |
Hypopharynx | 1 (2.3%) |
Treatment | |
Concurrent chemoradiotherapy | 40 (93%) |
Radiotherapy | 3 (7%) |
Stage | |
III | 4 (9%) |
IV | 39 (91%) |